Stephen Riley, radiotherapy physicist at Clatterbridge Centre for Oncology, Wirral.
Clatterbridge Centre for Oncology has been involved from day one in the development of the new dosimetry system Delta4, manufactured by Scandidos AV of Uppsala, Sweden and supplied by Oncology Systems Limited.
Today Delta4, with more than 20 systems installed in the UK, is one of the fastest growing physics technologies. Like any new technology, it can take several years to move from experimental design to market, and clinical collaboration is key to success. The Clatterbridge physics team started their collaboration with the manufacturer in 2006, and were the first UK hospital to clinically use the system for IMRT QA.
Stephen Riley, radiotherapy physicist at Clatterbridge who uses the technology on a regular basis, states: “Some of the early experimental work was carried out here and we were keen to start using it when it came to market in 2007 as we saw it as an improvement on our previous methods of IMRT QA.
“It was heavily used in our commissioning of Varian’s VMAT technology, and we started treating patients with VMAT in November 2008.”
See the full report on page 37 of the October 2010 issue of RAD Magazine.